Donald Saelinger, MD
Gastroenterology · Newport, KYNPI 1447295407
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 32.8% of the total. Reporting peaked in 2024 at $197 and has fallen 81.2% since, to $37 in 2025. That places this record below the midpoint for gastroenterology clinicians in KY, where the typical reported total is $3,388.
Across 26 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$154
- Regeneron Healthcare Solutions, Inc.$106
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$36
- Daiichi Sankyo Inc.$29
- Johnson & Johnson$22
- AstraZeneca$18
- plus $104 from 7 others
What the payments were for
- Food & beverage$470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$470 in reported general payments places this provider in the 10th percentile of 207 gastroenterology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CholestyramineCholestyramine (With Sugar) | 16 | $871 |
| Pantoprazole Sodium | 79 | $657 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 32 | $593 |
| Sucralfate | 13 | $261 |
| Dicyclomine Hcl | 17 | $189 |
| Omeprazole | 20 | $80 |
| Ondansetron Hcl | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Newport
- Gerald DrydenLouisville$2.1M
- Zahid SaeedCrestview Hills$442K
- Matthew CaveLouisville$340K
- Michael KreaseLouisville$322K
- Sunana SohiLouisville$220K
- Jeffrey TuvlinLouisville$202K
- Stephen McClaveLouisville$124K
- Uday ShankarHazard$64K
- Terrence BarrettLexington$57K
- Avinash AravantagiBowling Green$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.